• FCAD Emerges As the Ultimate Source of Halofuginone

    FCAD Emerges As the Ultimate Source of Halofuginone

    Brief Introduction of Halofuginone Chemical derivative of febrifugine, Halofuginone is a natural quinazolinone found in Chinese herb Dichora. Previously, the drug was used in veterinary medicine; however, today it is being developed for the treatment of scleroderma and has received orphan drug designation from FDA. Halofuginone is an inhibitor that inhibits the development of T
  • FCAD Successfully Developed Three New Electrolytes to Be Used In Lithium-Ion Batteries

    FCAD Successfully Developed Three New Electrolytes to Be Used In Lithium-Ion Batteries

    Previously, nickel-cadmium was the only batteries for charging portable electronics and other equipment. Ranging from wireless forms of communications to mobile computing, nickel-cadmium was a top choice. However, during the early 1990s, lithium-ion surfaced in the market, providing competition to the otherwise popular option. In the present day, lithium-ion has emerged as the most promising
  • FCAD Added Prostaglandin Analogues to Product Line

    FCAD Added Prostaglandin Analogues to Product Line

    Glaucoma is a leading cause of irreversible blindness in the United States and the rest of the world. More than three million Americans suffer from glaucoma. Furthermore, it is estimated that about 80 million people globally will be affected by 2020. Prostaglandin analog eye drops are considered first line treatment for glaucoma. These eye drops

  • Investing in Pharmaceutical Research for Carbohydrates to Improve Human Health

    Investing in Pharmaceutical Research for Carbohydrates to Improve Human Health

    Carbohydrates are the building blocks of a normal human cell, and are essential for its proper functioning. Carbohydrates feature as an important agent in disease causing pathologies, which includes inflammatory diseases, cancer, and cardiovascular diseases. They have a vast range of shapes and sizes, and due to this fact, they can be used to manufacture

  • Ulcho Develops State of the Art Carbohydrate based Drugs after Running Extensive Research Programs

    Ulcho Develops State of the Art Carbohydrate based Drugs after Running Extensive Research Programs

    Research and development in the field of carbohydrate based drugs is a contemporary addition to the world of chemistry and pharmaceuticals. Little is known regarding this feat, which is why Ulcho Biochemical Ltd continues its efforts of thorough and organized research in understanding and developing carbohydrate based drugs. Ulcho Biochemical Ltd is an independent R&D company under the umbrella

  • 10-MDP

    10-MDP

    Related Service Unique Polymer Design, saving millions of dollars for dental customers Application MDP (10-Methacryloyloxydecyl dihydrogen phosphate) convinces users by its special monomer structure: This phosphate monomer was extremely effective for enamel, dentin and on metal alloys. Consequently, the material including the MDP monomer, was introduced as a high-performance adhesive resin cement for the cementation